Christopher Otis to Biomarkers, Tumor
This is a "connection" page, showing publications Christopher Otis has written about Biomarkers, Tumor.
Connection Strength
0.471
-
Ersoy E, Cao QJ, Otis CN. HER2 Protein Overexpression and Gene Amplification in Tubo-Ovarian High-grade Serous Carcinomas. Int J Gynecol Pathol. 2022 07 01; 41(4):313-319.
Score: 0.145
-
Longacre TA, Broaddus R, Chuang LT, Cohen MB, Jarboe EA, Mutter GL, Otis CN, Zaino RJ. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium. Arch Pathol Lab Med. 2017 11; 141(11):1508-1512.
Score: 0.107
-
Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. J Cell Physiol. 2014 Sep; 229(9):1160-9.
Score: 0.090
-
Pantanowitz L, Otis CN. Myxoid liposarcoma. Diagn Cytopathol. 2007 May; 35(5):283-4.
Score: 0.054
-
Otis CN, Krebs PA, Albuquerque A, Quezado MM, San Juan X, Sobel ME, Merino MJ. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features. Int J Surg Pathol. 2002 Oct; 10(4):237-45.
Score: 0.039
-
El Hallani S, Arora R, Lin DI, M?sb?c A, Mateoiu C, McCluggage WG, Nucci MR, Otis CN, Parkash V, Parra-Herran C, Longacre TA. Mixed Endometrioid Adenocarcinoma and M?llerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma. Am J Surg Pathol. 2021 03 01; 45(3):374-383.
Score: 0.035